VALSARTAN — Class II drug recall D-816-2014
Terminated recall by Aidapak Services, LLC, reported 2014-01-29, distributed in AZ, CA, OR, WA. Labeling: Label Mixup: VALSARTAN, Tablet, 160 mg may have potentially been mislabeled as one of the following
| Recall number | D-816-2014 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Aidapak Services, LLC, Vancouver, WA, United States |
| Recall initiated | 2013-07-02 |
| Classified | 2014-01-20 |
| Reported by FDA | 2014-01-29 |
| Terminated | 2014-02-07 |
| Distributed | AZ, CA, OR, WA |
| Quantity | 1,260 tablets |
| Reason classes | labeling |
| Expiration dates | 2014-05-16, 2014-05-17, 2014-05-28, 2014-06-06, 2014-06-07, 2014-06-11, 2014-06-21, 2014-06-25 |
Product
VALSARTAN, Tablet, 160 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00078035934.
Reason for recall
Labeling: Label Mixup: VALSARTAN, Tablet, 160 mg may have potentially been mislabeled as one of the following drugs: PROGESTERONE, Capsule, 100 mg, NDC 00032170801, Pedigree: AD46320_1, EXP: 5/15/2014; CapsuleTOPRIL, Tablet, 6.25 mg (1/2 of 12.5 mg), NDC 00143117101, Pedigree: AD46312_4, EXP: 5/16/2014; MYCOPHENOLATE MOFETIL, Tablet, 500 mg, NDC 00004026001, Pedigree: AD49414_4, EXP: 5/17/2014;
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-816-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.